Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features (Q59706187)
Jump to navigation
Jump to search
scientific article published on 01 September 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features |
scientific article published on 01 September 2002 |
Statements
Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features (English)
Jason S Krumholtz
Gustavo F Carvalhal
Christian G Ramos
Deborah S Smith
Phataraporn Thorson
Peter A Humphrey
Kimberly A Roehl
William J Catalona
1 September 2002
469-73; discussion 473-4